| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX011 (ip) | mean tumor weight | saline | 2.5 mg/kg/injection | 84.0 | Antitumor endpoint evaluated on day 12; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 5.0 mg/kg/injection | 30.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 10.0 mg/kg/injection | 45.0 | Antitumor endpoint evaluated on day 12; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 10.0 mg/kg/injection | 31.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 10.0 mg/kg/injection | 29.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 10.0 mg/kg/injection | 24.0 | Antitumor endpoint evaluated on day 12; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 20.0 mg/kg/injection | 24.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 20.0 mg/kg/injection | 27.0 | Antitumor endpoint evaluated on day 12; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 20.0 mg/kg/injection | 20.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 05/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | saline | 30.0 mg/kg/injection | 19.0 | Antitumor endpoint evaluated on day 12; 07/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 1.0 mg/kg/injection | 70.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 2.0 mg/kg/injection | 46.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 4.0 mg/kg/injection | 54.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 5.0 mg/kg/injection | 40.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 6.0 mg/kg/injection | 49.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 10.0 mg/kg/injection | 22.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (oral) | mean tumor weight | carboxymethylcellulose (CMC) | 5.0 mg/kg/injection | 31.0 | Antitumor endpoint evaluated on day 12; 13/13 animals surviving on tox evaluation day (usually day 5) |
| Q01DX011 (oral) | mean tumor weight | carboxymethylcellulose (CMC) | 10.0 mg/kg/injection | 31.0 | Antitumor endpoint evaluated on day 12; 13/13 animals surviving on tox evaluation day (usually day 5) |